Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131700) titled 'Construction and Application Research of Bridging Technologies for Early Drug Development' on Sept. 5.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: China-Japan Friendship Hospital
Condition:
Lung cancer (lung adenocarcinoma), gastric cancer, colorectal cancer
Intervention:
Study 3: Exploration of drug sensitization mechanisms in lung adenocarcinoma organoids:None
Study 1: Standardization of tumor organoid model construction:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-15
Target Sample Size: Study 3: Exploration of drug sensit...